1. Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection
    Franziska M. Ippen et al, 2015, Journal of Oncology CrossRef
  2. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis
    Irina Zubatkina et al, 2017, Journal of Neurosurgery CrossRef
  3. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome
    Rupesh Kotecha et al, 2017, Journal of Neurosurgery CrossRef
  4. Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era
    James E. Bates et al, 2017, American Journal of Clinical Oncology CrossRef
  5. Metastatic melanoma: prognostic factors and survival in patients with brain metastases
    E. Frinton et al, 2017, J Neurooncol CrossRef
  6. null
    Quinn T. Ostrom et al, 2018 CrossRef
  7. Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors
    Ethan Ferrel et al, 2016, IJMS CrossRef
  8. Current treatment options of brain metastases and outcomes in patients with malignant melanoma
    Jadwiga Nowak-Sadzikowska et al, 2016, Reports of Practical Oncology & Radiotherapy CrossRef
  9. New Era in the Management of Melanoma Brain Metastases
    Hussein A. Tawbi et al, 2018, American Society of Clinical Oncology Educational Book CrossRef
  10. Advances in the systemic treatment of melanoma brain metastases
    I C Glitza Oliva et al, 2018 CrossRef
  11. Intensity Modulated Radiotherapy is a Well-Tolerated and Effective Treatment for the Long-Term Control of Intra-Abdominal and Retroperitoneal Oligometastatic Renal Cell Cancer
    Isabella Maund et al, 2018, KCA CrossRef
  12. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
    Paul Lesueur et al, 2018, Radiat Oncol CrossRef
  13. Clival metastasis of renal clear cell carcinoma: Case report and literature review
    Wei-Qi Zhang et al, 2018, WJCC CrossRef
  14. Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma
    Susanne Stera et al, 2019, Melanoma Research CrossRef
  15. null
    Sekwon Jang et al, 2016 CrossRef
  16. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: Opportunities and unanswered questions
    Jack Murrell et al, 2013, Cancer Treatment Reviews CrossRef
  17. Salvage stereotactic radiosurgery for brain metastases
    George Klironomos et al, 2013, Expert Review of Neurotherapeutics CrossRef
  18. Stereotactic radiosurgery for brain and spine metastases
    Patrick J. Bowden et al, 2014, Journal of Clinical Neuroscience CrossRef
  19. Radiochirurgie zerebraler Metastasen
    M. Kufeld et al, 2014, Onkologe CrossRef
  20. Using Higher Isodose Lines for Gamma Knife Treatment of 1 to 3 Brain Metastases Is Safe and Effective
    Kevin Shiue et al, 2014, Neurosurgery CrossRef
  21. Hirnmetastasen des Melanoms
    O. Kölbl et al, 2014, Onkologe CrossRef
  22. Strahlentherapie beim metastasierten Nierenzellkarzinom
    B. van Oorschot et al, 2015, Onkologe CrossRef
  23. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases
    Kirtesh R. Patel et al, 2015, Neuro Oncol CrossRef
  24. Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
    Henrik Hauswald et al, 2015, BMC Cancer CrossRef
  25. null
    William W. Wong et al, 2016 CrossRef
  26. Complications associated with immunotherapy for brain metastases
    Thuy T. Tran et al, 2019, Current Opinion in Neurology CrossRef
  27. Neurologic complications of melanoma
    Justine V. Cohen et al, 2019, Cancer CrossRef
  28. Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases
    Mutlay Sayan et al, 2019, Radiat Oncol J CrossRef
  29. Metastatic melanoma: Surgical treatment of brain metastases – Analysis of 110 patients
    Frances Anne McHugh et al, 2020, Journal of Clinical Neuroscience CrossRef
  30. Multidisciplinary Approach to Brain Metastasis from Melanoma; Local Therapies for Central Nervous System Metastases
    Naren Ramakrishna et al, 2013, American Society of Clinical Oncology Educational Book CrossRef
  31. Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
    Muhammad Khan et al, 2020, Front. Oncol. CrossRef
  32. Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
    Jakob Liermann et al, 2020, Front. Oncol. CrossRef
  33. Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA
    K. A. Kessel et al, 2021, Clin Transl Oncol CrossRef
  34. null
    Jeremy C. Ganz, 2022 CrossRef
  35. Estimating the Additive Benefit of Surgical Excision to Stereotactic Radiosurgery in the Management of Metastatic Brain Disease
    Matthew R. Quigley et al, 2015 CrossRef
  36. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment
    David Ly et al, 2015, JNS CrossRef
  37. Stereotactic radiosurgery for intraventricular brain metastases
    Benjamin Farnia et al, 2014, JNS CrossRef
  38. Stereotactic Radiosurgery and Anti-PD-1 + CTLA-4 Therapy, Anti-PD-1 Therapy, Anti-CTLA-4 Therapy, BRAF/MEK Inhibitors, BRAF Inhibitors, or Conventional Chemotherapy for the Management of Melanoma Brain Metastases
    Ammoren E. Dohm et al, 2023, European Journal of Cancer CrossRef
  39. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy
    Nipun Verma et al, 2024, Advances in Radiation Oncology CrossRef